Xia Wu

Dr. Xia Wu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
ZGZhi Guo
Zhi Guo
HSHong Shi
Hong Shi
WLWentao Li
Wentao Li
DLDongmei Lin
Dongmei Lin
CWChangli Wang
Changli Wang
SWSen Wang
Sen Wang
Biopsy has been used to diagnose thoracic diseases for more than a century. Percutaneous needle biopsy plays a crucial role in the diagnosis, staging, and treatment planning for tumors in the lungs, thoracic wall, hilum, and mediastinum. With the continuous improvement in imaging techniques, the range of clinical applications for percutaneous needle biopsy is also expanding. It has become important to improve Chinese professionals’ and technicians’ understanding of percutaneous transthoracic needle biopsy (PTNB) in order to standardize operating procedures and to strengthen perioperative management. However, there is currently no Chinese expert consensus that provides systematic standardization and guidance for PTNB in clinical practice. The Committee of Chinese Society of Interventional Oncology (CSIO) of the Chinese Anti‐Cancer Association (CACA) initiated a Chinese multidisciplinary expert consensus on PTNB. The consensus includes image‐guided methods, indications, contraindications, multidisciplinary team recommendations, biopsy procedures, daytime/outpatient biopsy, complications, pathological examination, and management of negative results.

26 November 2017 in Biofouling
Verified
Journal Article
Open access
DWDongwei Wang
Dongwei Wang
XWXia Wu
Xia Wu
LLLixia Long
Lixia Long
XYXu-Bo Yuan
Xu-Bo Yuan
QZQinghua Zhang
Qinghua Zhang
WCWei Cong
Wei Cong
To improve the antifouling (AF) properties of photobioreactors (PBR) for microalgal cultivation, using trihydroxymethyl aminomethane (tris) as the linking agent, a series of polyethylene (PE) films grafted with sulfobetaine (PE-SBMA) with grafting density ranging from 23.11 to 112 μg cm−2 were prepared through surface-initiated atom transfer radical polymerization (SI-ATRP). It was found that the contact angle of PE-SBMA films decreased with the increase in the grafting density. When the grafting density was 101.33 μg cm−2, it reached 67.27°. Compared with the PE film, the adsorption of protein on the PE-SBMA film decreased by 79.84% and the total weight of solid and absorbed microalgae decreased by 54.58 and 81.69%, respectively. Moreover, the transmittance of PE-SBMA film recovered to 86.03% of the initial value after cleaning, while that of the PE film recovered to only 47.27%. The results demonstrate that the AF properties of PE films were greatly improved on polySBMA-grafted surfaces.

1 March 2012 in Carbohydrate Polymers
Verified
Journal Article
Closed access
CXChunlin Xu
Chunlin Xu
YLYinghong Li
Yinghong Li
MDMin Dong
Min Dong
XWXia Wu
Xia Wu
XWXiaochuan Wang
Xiaochuan Wang
YXYusen Xiao
Yusen Xiao

1 March 2026 in Genes & Diseases
Verified
Journal Article
Open access
STSiqi Tang
Siqi Tang
WLWenshu Luo
Wenshu Luo
SWShihao Wu
Shihao Wu
MYMeng Yuan
Meng Yuan
JWJiashuo Wen
Jiashuo Wen
XXXiao Xiao
Xiao Xiao
Brain-derived neurotrophic factor (BDNF) can protect neurons from apoptosis and maintain normal synaptic structures, indicating a significant potential for Alzheimer's disease (AD) treatment. However, the method of in vivo BDNF delivery requires further optimization, and the therapeutic efficacy of BDNF in AD animal models needs to be further evaluated. Here, we demonstrated that a newly engineered adeno-associated virus (AAV) serotype termed AAVT42 showed better tropism for neurons than AAV9 in the central nervous system (CNS). We analyzed the therapeutic potentials of AAVT42-delivered BDNF in three AD mouse models: amyloid precursor protein/presenilin-1 (APP/PS1), rTg4510, and 3 × Tg. Long-term BDNF expression in the hippocampus mitigated neuronal degeneration or loss in these AD mice, and alleviated their cognitive impairment, with no discernible effect on amyloid-β deposition or tau phosphorylation. Furthermore, transcriptomic analysis in 3 × Tg mice revealed that BDNF orchestrated the up-regulation of genes associated with neuronal structural organization and synaptic transmissions, such as Neuropeptide Y (Npy), Corticotropin-releasing hormone (Crh), Tachykinin precursor 1 (Tac1), and the down-regulation of Bone morphogenetic proteins (Bmps). Our study highlighted the efficacy of AAVT42 in gene delivery to CNS and validated the therapeutic benefits of BDNF in treating AD, which will be useful for future translational research on AD treatment using an AAV delivery system.

20 January 2025 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
KZKaiyi Zhou
Kaiyi Zhou
MYMeng Yuan
Meng Yuan
JSJiabao Sun
Jiabao Sun
FZFeixu Zhang
Feixu Zhang
XLXinting Li
Xinting Li
XWXia Wu
Xia Wu

15 April 2020 in Journal of Experimental Zoology Part B: Molecular and Developmental Evolution
Verified
Journal Article
Closed access
PDF file
XWXia Wu
Xia Wu
SHShuxiang Hu
Shuxiang Hu
LWLingling Wang
Lingling Wang
YLYan Li
Yan Li
HYHaiquan Yu
Haiquan Yu